nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRA3—Graves' disease	0.783	1	CbGaD
Adinazolam—CYP2C19—Methimazole—Graves' disease	0.065	0.674	CbGbCtD
Adinazolam—CYP3A4—Methimazole—Graves' disease	0.0314	0.326	CbGbCtD
Adinazolam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00398	0.038	CbGpPWpGaD
Adinazolam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00392	0.0374	CbGpPWpGaD
Adinazolam—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00371	0.0354	CbGpPWpGaD
Adinazolam—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00367	0.035	CbGpPWpGaD
Adinazolam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00335	0.032	CbGpPWpGaD
Adinazolam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00326	0.0311	CbGpPWpGaD
Adinazolam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00314	0.03	CbGpPWpGaD
Adinazolam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00312	0.0298	CbGpPWpGaD
Adinazolam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00311	0.0296	CbGpPWpGaD
Adinazolam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00307	0.0293	CbGpPWpGaD
Adinazolam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00296	0.0283	CbGpPWpGaD
Adinazolam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00268	0.0256	CbGpPWpGaD
Adinazolam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00244	0.0233	CbGpPWpGaD
Adinazolam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0024	0.0229	CbGpPWpGaD
Adinazolam—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00227	0.0217	CbGpPWpGaD
Adinazolam—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00225	0.0214	CbGpPWpGaD
Adinazolam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00205	0.0196	CbGpPWpGaD
Adinazolam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00199	0.019	CbGpPWpGaD
Adinazolam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00193	0.0184	CbGpPWpGaD
Adinazolam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00191	0.0183	CbGpPWpGaD
Adinazolam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00188	0.0179	CbGpPWpGaD
Adinazolam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00165	0.0157	CbGpPWpGaD
Adinazolam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00164	0.0157	CbGpPWpGaD
Adinazolam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00157	0.015	CbGpPWpGaD
Adinazolam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00129	0.0124	CbGpPWpGaD
Adinazolam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.00127	0.0122	CbGpPWpGaD
Adinazolam—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.00121	0.0115	CbGpPWpGaD
Adinazolam—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.00119	0.0114	CbGpPWpGaD
Adinazolam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.00109	0.0104	CbGpPWpGaD
Adinazolam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00106	0.0101	CbGpPWpGaD
Adinazolam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00102	0.00975	CbGpPWpGaD
Adinazolam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.00101	0.00968	CbGpPWpGaD
Adinazolam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000996	0.00951	CbGpPWpGaD
Adinazolam—GABRR3—eye—Graves' disease	0.000978	0.122	CbGeAlD
Adinazolam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000871	0.00831	CbGpPWpGaD
Adinazolam—GABRR2—eye—Graves' disease	0.000848	0.106	CbGeAlD
Adinazolam—GABRR1—eye—Graves' disease	0.000817	0.102	CbGeAlD
Adinazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000757	0.00723	CbGpPWpGaD
Adinazolam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000755	0.0072	CbGpPWpGaD
Adinazolam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000744	0.0071	CbGpPWpGaD
Adinazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000723	0.0069	CbGpPWpGaD
Adinazolam—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000704	0.00671	CbGpPWpGaD
Adinazolam—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000695	0.00663	CbGpPWpGaD
Adinazolam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000674	0.00643	CbGpPWpGaD
Adinazolam—Chlordiazepoxide—GABRA3—Graves' disease	0.000657	0.082	CrCbGaD
Adinazolam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000643	0.00614	CbGpPWpGaD
Adinazolam—GABRG3—pituitary gland—Graves' disease	0.000636	0.0795	CbGeAlD
Adinazolam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000635	0.00606	CbGpPWpGaD
Adinazolam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000617	0.00589	CbGpPWpGaD
Adinazolam—Clorazepate—GABRA3—Graves' disease	0.000614	0.0767	CrCbGaD
Adinazolam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000596	0.00568	CbGpPWpGaD
Adinazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000595	0.00568	CbGpPWpGaD
Adinazolam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000592	0.00565	CbGpPWpGaD
Adinazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000586	0.00559	CbGpPWpGaD
Adinazolam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000581	0.00555	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000569	0.00543	CbGpPWpGaD
Adinazolam—Alprazolam—GABRA3—Graves' disease	0.000556	0.0694	CrCbGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000555	0.00529	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000548	0.00523	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000543	0.00518	CbGpPWpGaD
Adinazolam—Cinolazepam—GABRA3—Graves' disease	0.000542	0.0677	CrCbGaD
Adinazolam—Quazepam—GABRA3—Graves' disease	0.000539	0.0673	CrCbGaD
Adinazolam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000529	0.00505	CbGpPWpGaD
Adinazolam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000522	0.00498	CbGpPWpGaD
Adinazolam—Flunitrazepam—GABRA3—Graves' disease	0.000509	0.0636	CrCbGaD
Adinazolam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000508	0.00485	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000501	0.00478	CbGpPWpGaD
Adinazolam—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000494	0.00471	CbGpPWpGaD
Adinazolam—GABRB1—pituitary gland—Graves' disease	0.000492	0.0614	CbGeAlD
Adinazolam—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000487	0.00465	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000487	0.00464	CbGpPWpGaD
Adinazolam—Estazolam—GABRA3—Graves' disease	0.000476	0.0595	CrCbGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00047	0.00448	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000467	0.00445	CbGpPWpGaD
Adinazolam—Halazepam—GABRA3—Graves' disease	0.000463	0.0578	CrCbGaD
Adinazolam—Nitrazepam—GABRA3—Graves' disease	0.00046	0.0574	CrCbGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000458	0.00437	CbGpPWpGaD
Adinazolam—Fludiazepam—GABRA3—Graves' disease	0.000449	0.0561	CrCbGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000447	0.00427	CbGpPWpGaD
Adinazolam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000446	0.00425	CbGpPWpGaD
Adinazolam—GABRA4—pituitary gland—Graves' disease	0.000444	0.0554	CbGeAlD
Adinazolam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000441	0.0042	CbGpPWpGaD
Adinazolam—GABRP—pituitary gland—Graves' disease	0.00044	0.055	CbGeAlD
Adinazolam—Prazepam—GABRA3—Graves' disease	0.000438	0.0547	CrCbGaD
Adinazolam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.000436	0.00416	CbGpPWpGaD
Adinazolam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000433	0.00413	CbGpPWpGaD
Adinazolam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000418	0.00399	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000417	0.00398	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000416	0.00397	CbGpPWpGaD
Adinazolam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000415	0.00396	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000412	0.00393	CbGpPWpGaD
Adinazolam—Flurazepam—GABRA3—Graves' disease	0.000409	0.051	CrCbGaD
Adinazolam—Triazolam—GABRA3—Graves' disease	0.000408	0.051	CrCbGaD
Adinazolam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000408	0.00389	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.0004	0.00382	CbGpPWpGaD
Adinazolam—Oxazepam—GABRA3—Graves' disease	0.000396	0.0494	CrCbGaD
Adinazolam—GABRA3—thyroid gland—Graves' disease	0.000392	0.049	CbGeAlD
Adinazolam—Temazepam—GABRA3—Graves' disease	0.000391	0.0488	CrCbGaD
Adinazolam—GABRB3—eye—Graves' disease	0.000384	0.048	CbGeAlD
Adinazolam—Midazolam—GABRA3—Graves' disease	0.000379	0.0473	CrCbGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000377	0.00359	CbGpPWpGaD
Adinazolam—GABRG2—pituitary gland—Graves' disease	0.000371	0.0464	CbGeAlD
Adinazolam—GABRB3—connective tissue—Graves' disease	0.00037	0.0462	CbGeAlD
Adinazolam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000366	0.00349	CbGpPWpGaD
Adinazolam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000356	0.0034	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000353	0.00337	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000351	0.00335	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000344	0.00329	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000343	0.00327	CbGpPWpGaD
Adinazolam—GABRA2—adipose tissue—Graves' disease	0.000338	0.0422	CbGeAlD
Adinazolam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000338	0.00322	CbGpPWpGaD
Adinazolam—GABRE—pituitary gland—Graves' disease	0.000336	0.042	CbGeAlD
Adinazolam—GABRE—adipose tissue—Graves' disease	0.000335	0.0418	CbGeAlD
Adinazolam—Diazepam—GABRA3—Graves' disease	0.000325	0.0405	CrCbGaD
Adinazolam—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000319	0.00305	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000315	0.00301	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000301	0.00287	CbGpPWpGaD
Adinazolam—GABRE—thyroid gland—Graves' disease	0.00029	0.0362	CbGeAlD
Adinazolam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000289	0.00275	CbGpPWpGaD
Adinazolam—GABRB3—pituitary gland—Graves' disease	0.000285	0.0356	CbGeAlD
Adinazolam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.00028	0.00267	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.00027	0.00258	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000269	0.00256	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000264	0.00252	CbGpPWpGaD
Adinazolam—GABRB3—thyroid gland—Graves' disease	0.000246	0.0307	CbGeAlD
Adinazolam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000235	0.00224	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000231	0.0022	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000224	0.00214	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000184	0.00176	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000182	0.00173	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000172	0.00164	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00017	0.00162	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000155	0.00148	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000151	0.00144	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000145	0.00139	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000144	0.00138	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000142	0.00135	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000124	0.00118	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	7.21e-05	0.000688	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	7.21e-05	0.000688	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	5.23e-05	0.000499	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GC—Graves' disease	3.21e-05	0.000306	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.43e-05	0.000232	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GC—Graves' disease	1.93e-05	0.000184	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.46e-05	0.00014	CbGpPWpGaD
